Cargando…
1524. Are Providers Shifting from NTF to Fosfomycin for Inpatient UTI? Big Data Reveals Small Shifts
BACKGROUND: Fosfomycin (FOS) and NTF (NTF) are IDSA guideline approved drugs for acute cystitis in women. However, their activity against multi drug-resistant Gram-negatives may be driving increased use among inpatients with more complicated UTI. We evaluated trends in inpatient prescribing of these...
Autores principales: | Gupta, Kalpana, Goetz, Matthew B, Jones, Makoto, Strymish, Judith M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253901/ http://dx.doi.org/10.1093/ofid/ofy210.1353 |
Ejemplares similares
-
104. Accuracy of ChatGPT for UTI Diagnosis and Management Questions
por: Gupta, Kalpana, et al.
Publicado: (2023) -
Fosfomycin versus Nitrofurantoin for the Treatment of Lower UTI in Outpatients
por: Sharma, Shraddha, et al.
Publicado: (2021) -
2841. Skipping the Urine Culture before Genitourinary Surgeries May Not be Associated with Increased Risk of Postoperative UTI
por: Plasencia, Juan Teran, et al.
Publicado: (2023) -
Susceptibility pattern of oral antimicrobials in uncomplicated UTI: Does fosfomycin still stand effective?
por: Batra, Priyam, et al.
Publicado: (2020) -
Is fosfomycin as effective as claimed on MDR Gram-negative bacteria causing UTI? [Letter]
por: Singh, Geeta, et al.
Publicado: (2019)